Used as a potent inhibitor in pharmaceutical research, particularly in the development of kinase-targeted therapies. Its structure enables selective interference with specific signaling pathways involved in inflammatory diseases and cancer progression. Commonly applied in preclinical studies to evaluate efficacy in cell-based assays and animal models, supporting the design of new therapeutic agents. Also utilized in structure-activity relationship (SAR) studies to optimize drug-like properties such as potency, selectivity, and metabolic stability.